The president of Atrys Health gave a positive assessment of the 2021 financial year, in which the company launched the takeover bid for Aspy, various acquisitions...
The Spanish biotech company AcceXible has recently entered the market in Colombia. AcceXible expects to have a turnover of $491,000 (€450,000) in 2022. The company received...
For the time being, Devicare is launching this product in the Netherlands. At the beginning of 2021, Devicare closed a financing round of $3 million. The...
The six listed pharmaceutical companies close the first quarter of 2022 with a stock market value of $16.7 billion (€15.1 billion). The biggest decline was registered...
Integra Therapeutics will allocate the funds to the development of the FiCAT platform prototype and preclinical validation. The Catalan company has also raised sufficient capital to...
The figures in the pharmaceuticals area are cemented especially by the performance of Bayer's cardiovascular treatments and for the prevention of age-related ophthalmological diseases. Another highlight...
Miwendo receives funds from the European Union (EU) to advance in cancer detection. Colorectal cancer is the most prevalent cancer in Spain and, worldwide, 1.4 million...
With the publication of the results of this trial, which will probably take place in March or April, Neurofix Pharma will increase its valuation and will...
Pfizer, Johnson&Johnson (J&J) and AstraZeneca achieved a combined profit of $42.972 billion in 2021, up from $27.017 billion a year earlier, according to results released by...
Based in Granada, Regemat 3D is one of the main players in this new industry. The company manufactures tissue and organ biofabrication systems, bioprinters, and bioreactors,...